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Abstract The stimulation of N M D A receptor increased 
[3H]GABA release from preloaded cultured retina cells. This 
effect appears to be mediated by N O production, since addition 
of L-NA reduces NMDA-evoked |3H]GABA release. Spermine/ 
NO complex, an NO donor, mimics the effect produced by 
NMDA. The addition of zaprinast, a phosphodiesterase inhibi-
tor, as well as 8-Br-cGMP enhances the NMDA-evoked 
|3H]GABA release. These results agree with the existence in 
chick retina cells of NO/cGMP pathways and support a role for 
NO in NMDA-evoked events. The activation of this receptor 
complex through maturative stages of the retina together with 
the NO-mediated increase in GABA release may account for 
N M D A differentiative effect in culturing retina cells. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
N O is a highly reactive radical species endowed with mes-
senger functions in the central nervous system [1]. In the ver-
tebrate brain the activation of N M D A subtype of glutamate 
receptor enhances neuronal Ca2+-infiux which in turn stimu-
lates the neuronal type of N O synthase (nNOS) to generate 
N O and this is responsible for NMDA-media ted c G M P accu-
mulation by stimulation of the soluble form of guanylate cy-
clase [2]. In addition, N O has been involved in other impor-
tant N M D A receptor-mediated mechanisms including 
neurotransmitter release [3]. More recently, it has became ap-
parent that a functional L-arginine-NO-cGMP pathway is 
present since the early stages of development in chick embryo 
retina [4,5]. For instance, we have previously shown that 
Ca 2 + -dependent N O S activity is present in 9-day-old chick 
embryo retina and more importantly this can be stimulated 
through N M D A receptor activation [5,6]. Collectively these 
data led us to hypothesize that the occurrence of a functional 
N O / c G M P pathway, which can be modulated by N M D A 
receptor activation, may have a role in the maturat ion process 
of chick embryo retina. To test this hypothesis we have 
studied the effect of drugs which interfere with the NO/ 
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c G M P pathway on the NMDA-evoked [3H]GABA release 
in chick embryo retina cells at different stages of culture dif-
ferentiation. The results yielded by the present study support a 
role for N O / c G M P pathway in NMDA-evoked G A B A re-
lease, and this may account for the differentiative effect of 
N M D A in cultured retina cells [7,8]. 
2. Materials and methods 
L-NA, D-NA, MK-801, and spermine/NO complex were purchased 
from Research Biochemicals International (Natick, MA); L-
[,4C]arginrne (300 mCi/mmol) and [3H]GABA (100 Ci/mmol) were 
from Amersham; BH4 was from ICN Biomedicals (Aurora, OH). 
NMDA, 8-Br-cGMP, IBMX and other chemicals were from Sigma 
(St. Louis, MO). 2-0-propoxyphenyl-8-azapurine-6-one (Zaprinast), a 
phosphodiesterase inhibitor, was generously provided by Rhone-Pou-
lenc (Dagenham, UK). 
Primary cultures of cells were prepared using retinas from 8-day-old 
chick embryos, as reported by Nascimento and de Mello [9]. Trypsi-
nized tissue was centrifuged at 500 Xg for 1 min and supernatant 
discarded. The pellet was resuspended in 5 ml of BME (Earle's salts) 
containing 5% fetal calf serum and mechanically dissociated. Then the 
cells were plated in 35 mm plastic dishes (30X106 cells/dish) and 
transferred to a 37°C incubator under humidified atmosphere of 
95% air, 5% C0 2 . 
In order to evaluate NMDA response at different stages of culture 
differentiation we measured NO synthase activity after 3 (E8C3) and 
6 days (E8C6) of cells in culture. Retina cells were collected and 
suspended in 20 mM HEPES salt buffer composed of 110 mM 
NaCl, 5.4 mM KC1, 1.8 mM CaCl2, 25 mM glucose and 58.4 mM 
sucrose (pH 7.4). Cells were distributed into assay tubes (1 X 106 cells) 
and incubated with L-[U-MC]arginine (0.6 uCi, 80 nM), BH4 (10 uM), 
and indicated agonist or drugs, for 45 min at 37°C. Reactions were 
stopped by addition of 750 ul of 20 mM HEPES salt buffer containing 
4 mM EDTA. After centrifugation at 300Xg for 1 min, cell pellets 
were lysed by addition of 1 ml of 0.3 M HCIO4. Appropriate aliquot 
of supernatant, obtained by centrifugation at 800 X g for 5 min, was 
passed through Dowex AG50W-X8 (Na~ form), following by wash-
ing with 1 ml of water. [U-14C]citrulline formation was measured 
using a liquid scintillation counter. Preliminary experiments showed 
that NMDA-stimulated NO synthesis was linear as a function of time 
(up to 45 min) as well as for protein (up to 300 |ig). 
[3H]GABA release was assayed as described by Nascimento and de 
Mello [9]. The cultures at E8C3 and E8C6 stages were preincubated 
for 2 h in 1 ml of fresh BME containing [3H]GABA (5Xl0~8 M), 
buffered at pH 7.35 with 20 mM HEPES. The medium was removed 
and the cultures washed 3 times with 2 ml Hanks' solution pH 7.4. 
Cells were then superfused with Hanks' solution at 37°C, in the pres-
ence of indicated drugs. Agonists or antagonists were used at the 
concentration able to give maximal effect as previously reported [6]. 
Experiments using NMDA were performed in Mg2+-free Hanks' sol-
ution. The superfusion proceeded by performing successive changes of 
0.5 ml of the bathing medium at intervals of 5 min. Samples of super-
fusates were collected and radioactivity was measured. The 
[3H]GABA released at 5 min interval was plotted as the percentage 
of the total counts taken up by the cells. The total counts represent 
the radioactivity released during the superfusion plus the radioactivity 
remaining in the cells at the end of superfusion. cGMP contents were 
measured by radioimmunoassay (Amersham). 
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Fig. 1. Effect of NMDA on the NO synthesis from chick embryo 
retina cells at various stages of culturing. Cells from retinas of 8-
day-old chick embryos were cultured for 3 (E8C3) or 6 days 
(E8C6). Intact cells were incubated with or without NMDA (100 
u,M) in the presence or absence of arginine analogues, such as L-
NA (10-100 ixM) and D-NA (100 uM). The NOS activity was 
measured by monitoring the conversion of L-arginine into citrulline. 
Data are means ± S.E.M. from 3 ^ independent experiments per-
formed in triplicate. *P<0.01, **P< 0.001 in comparison to con-
trols, unpaired two tailed Student's Mest. 
3. Results 
In agreement with our previous observations made in intact 
chick embryo retina preparations, exposure of chick embryo 
retina cells (E8C6) to NMDA increases NOS activity by 0.5-
and 6-fold according to the low (10 uM) and high (100 uM) 
dose used of the NMDA receptor agonist. In Fig. 1 we show 
that the stimulation of NOS activity seems to correlate with 
the age of cultures, since NMDA-induced increase of enzyme 
activity was greater in chick embryo retina cells cultured for 
6 days than in those cultured for 3 days. The stimulated en-
zyme activity was inhibited in a stereoselective fashion by the 
NOS inhibitor, L-NA (10-100 uM). 
As reported in Table 1, exposure of these cultures to 
NMDA (100 |iM) also caused a 3-fold increase in [3H]GABA 
release. This effect appears to be mediated through NMDA 
receptor-stimulated NO synthesis. In fact, both competitive 
(LY 274614; 100 uM) and non-competitive (MK-801; 10 
uM) NMDA receptor antagonists and the NOS inhibitor L-
NA (100 uM) significantly reduced NMDA-enhanced 
[3H]GABA release. 
To further involve NO in the mechanism underlying GABA 
release, the latter has been studied in chick embryo retina cell 
cultures exposed to spermine/NO (100 uM), a slow spontane-
D Control 
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Fig. 2. NO-evoked release of [3H]GABA from chick retina cell cul-
tures. Cultures (E8C6) were loaded by incubation with [3H]GABA 
for 2 h at 37°C. Then superfused with spermine/NO complex (100 
u,M), in the presence or absence of haemoglobin (Hb, 10 uM), or 
100 uM spermine alone. For the evaluation of [3H]GABA release 
see Section 2. Data are means ± S.E.M. from six experiments per-
formed in triplicate. *P<0.01 in comparison to controls, unpaired 
two tailed Student's Mest. 
ous releaser of this nitrogen radical, that appears to be more 
potent than sodium nitroprusside [10]. Under these conditions 
an approximately 3-fold increase in background [3H]GABA 
release was observed (Fig. 2). The NO donor was added at the 
concentration able to produce the maximal effect on amino 
acid release from intact chick retina [6]. The effect of sper-
mine/NO is due to NO released by the donor, because Hb (10 
uM), an NO trapping agent, fully prevented the stimulated 
GABA release. This observation would exclude that under 
our present conditions a stimulatory effect of spermine acting 
on the polyamine modulatory site in the NMDA receptor 
complex [11] may take place. The latter deduction is strength-
ened by the evidence that in a concentration range as high as 
0.5-1.5 mM, spermine weakly increased (22-37%) [3H]GABA 
release in chick retina cell cultures. However, in Fig. 2 we 
show that no detectable increases were apparent when sper-
mine was added at equimolar concentration of spermine/NO 
complex (100 uM). Interestingly, as reported in Fig. 3 appli-
cation of NMDA (100 uM) or spermine/NO (100 uM) signifi-
cantly increases cGMP levels, suggesting that the NMDA 
subtype of glutamate receptor modulates a fully functional 
NO/cGMP pathway in developing chick embryo retina cells. 
This hypothesis is further supported by the observed enhance-
ment of NMDA-evoked [3H]GABA release in E8C6 cultures 
exposed (10 min before and for duration of NMDA applica-
tion) to inhibitors of phosphodiesterase, such as IBMX (100 
uM) or zaprinast (10 uM). As reported in Table 2, phospho-
Table 1 
[3H]GABA release from chick embryo retina cells after NMDA activation 
% [3H]GABA release 
E8C3 E8C6 
Control 
NMDA (100 uM) 
NMDA+MK-801 (10 |0,M) 
NMDA+LY 274614 (100 uM) 
NMDA+L-NA (100 |xM) 
1.92±0.18 
5.45 ±0.61** 
2.45 ± 0.28 
2.7310.32 
2.98 ±0.37 
2.75 ±0.41 
8.23 ±0.78* 
4.34 ±0.51 
4.91 ±0.47 
4.73 ±0.63 
Retina cells at E8C3 and E8C6 stages of culturing were incubated with [3H]GABA for 2 h at 37°C. Then the non-incorporated radioactivity was 
washed out, and the cultures were superfused with Mg2+-free Hanks' solution, or NMDA in Mg2+-free Hanks' solution as described in Section 2. 
Antagonists of NMDA at indicated concentrations and L-NA were added to cultures 5 min before agonist addition. For the evaluation of 
[3H]GABA release see Section 2. The values shown represent the mean ± S.E.M. from five experiments in triplicate. 
**p< 0.001 in comparison to controls, unpaired two tailed Student's Mest. 
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diesterase inhibitors enhances NMDA-mediated release by ap-
proximately 22-55%, with no appreciable effect on basal 
[3H]GABA release (data not shown). In similar experiments 
it has been found that zaprinast (10 (J.M) produces a 44% 
increase of spermine/NO-induced release. Not surprisingly, 
in unstimulated chick embryo retina cell cultures the exposure 
to 8-Br-cGMP (1 mM), the enzyme-resistant cGMP analogue, 
yielded a significant increase in [3H]GABA release (see Table 
2). 
4. Discussion 
The present experiments have shown that activation of the 
NMDA subtype of glutamate receptor stimulates the release 
of [3H]GABA in chick embryo retina cell cultures. In fact, two 
selective antagonists (e.g. LY 274614 and MK-801) of this 
receptor subtype abolished NMDA-evoked release. A second 
important suggestion is that the mechanism through which 
NMDA receptor mediates this effect, involves stimulation of 
the NO/cGMP pathway because the selective NOS inhibitor 
L-NA, but not the less active isomer, D-NA prevented 
NMDA stimulation of [3H]GABA release. In line with a 
role for NO, when retina cell cultures were exposed to the 
NO donor spermine/NO complex, an increase on [3H]GABA 
release was observed, an effect, this latter, abolished by the 
NO trapping agent, Hb. Furthermore, the inhibitors of phos-
phodiesterase activity, such as zaprinast and IBMX, enhanced 
NMDA-evoked release likewise zaprinast did when co-applied 
with spermine/NO. Support for a role of NO/cGMP pathway 
in NMDA-evoked [3H]GABA release also comes from the 
evidence that 8-Br-cGMP, an enzyme-resistant cGMP ana-
logue, with low membrane permeability, increases the release 
of [3H]GABA in unstimulated retina cell cultures. In addition 
to the findings on the modulation operated by NMDA recep-
tor stimulation in a differentiative dependent fashion in chick 
embryo retina [12], our results show that NO/cGMP pathway 
may play a role in the control of [3H]GABA release. This 
appears to be of great importance for our understanding of 
the mechanisms underlying retina cell differentiation and 
function. Several evidence implicate NO in fundamental proc-
Table 2 
Effect of 8-Br-cGMP and phosphodiesterase inhibitors on NO-
evoked [3H]GABA release from chick embryo retina cells 
% [3H]GABA release 
Basal 2.75 ±0.40 
8-Br-cGMP (0.5 mM) 3.98 ± 0.42 
8-Br-cGMP (1.0 mM) 5.72±0.65a 
NMDA (100 |xM) 8.23 ± 0.91 
NMDA+Zaprinast (10 uM) 12.77 ± 1.35b 
NMDA+IBMX (100 uM) 10.02 ± 1.25 
Spermine/NO (100 uM) 6.76 ± 0.81 
Spermine/NO+Zaprinast (10 uM) 9.73 ± 0.94c 
Retina cells at E8C6 stages of culturing were incubated with 
[3H]GABA (5X10~8 M) for 2 h at 37°C, and thereafter superfused 
in the presence of 8-Br-cGMP at indicated concentrations. Zaprinast 
and IBMX were added 10 min before the addition of NMDA or 
spermine/NO complex. For the evaluation of [3H]GABA release see 
Section 2. Data are means ±S.E.M. from 5-6 independent experi-
ments performed in triplicate. 
aP < 0.05 in comparison to basal value. 
h'cP < 0.05 in comparison to NMDA and NO donor alone, respec-
tively. ANOVA with Newman-Keuls multiple comparison post-hoc 
test. 
n * 
□ Control 
UNMDA 
H Spermine/NO 
Fig. 3. Effects of NMDA (100 uM) and spermine/NO complex (100 
u,M) on cGMP levels in E8C6 chick embryo retina cells, during 20 
min incubation. cGMP levels were measured by radioimmunoassay. 
Data are means ± S.E.M. from 3-A independent experiments per-
formed in triplicate. *P < 0.01 in comparison to controls, unpaired 
two tailed Student's Mest. 
esses concerned with nervous tissue cell development such as 
neurotransmitter release [3], synaptogenesis [13] etc. and the 
NO forming enzyme is known to undergo per se developmen-
tal changes in the retina and in several areas of the brain 
[5,14]. Furthermore, it is well established that differentiation 
of different nerve cells in culture operated by depolarizing 
conditions involves NMDA-mediated control of GABA re-
lease as well as the release of the neurotransmitters [8]. There-
fore, it is conceivable that NO, a highly reactive and rapidly 
diffusible radical species, may represent the key messenger 
molecule through which maturative processes are controlled 
in chick embryo retina. 
Previous experiments carried out in our laboratory using 
intact retina preparations failed to implicate cGMP in 
NMDA-mediated neurotransmitter release [6] seemingly be-
cause of technical difficulties generated by the presence of 
cytoarchitectural tissue organization in intact retina model. 
Conversely, in the present experiments, monolayer cell cul-
tures from chick retina display characteristics of neuroblasts 
induced to differentiate showing at E8C6 a typical 'neuritic' 
pattern [15]. This observation together with our present results 
make chick embryo retina cell cultures more suitable for the 
characterization of neurochemical processes related to retina 
development and differentiation. 
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